Soliris

Initial Approval

Eculizumab (genetical recombination)

Approval Information

Brand NameSoliris
Generic NameEculizumab (genetical recombination)
ApprovedApril 2010
TypeInitial Approval

Want structured data, translation summaries & alerts?

PharmaLens is building the most comprehensive English-language PMDA intelligence platform. Join the waitlist for early access.

Join the Waitlist

Source: PMDA Website. Review reports are provided under Japan's Public Data License v1.0. Translations and structured data by PharmaLens are unofficial and for reference only.